CorMedix Inc. Files 8-K
Ticker: CRMD · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1410098
| Field | Detail |
|---|---|
| Company | Cormedix Inc. (CRMD) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory
TL;DR
CorMedix filed a routine 8-K, no major news.
AI Summary
CorMedix Inc. filed an 8-K on June 23, 2025, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this form type.
Why It Matters
This filing indicates CorMedix Inc. is meeting its regulatory reporting obligations with the SEC. It does not disclose new material information that would immediately impact the company's stock.
Risk Assessment
Risk Level: low — The filing is a standard SEC report and does not contain any new material information or significant events.
Key Players & Entities
- CorMedix Inc. (company) — Registrant
- June 23, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-34673 (identifier) — Commission File Number
- 20-5894890 (identifier) — I.R.S. Employer Identification No.
- 300 Connell Drive, Suite 4200 (address) — Principal executive offices
- Berkeley Heights, NJ 07922 (address) — Principal executive offices
- (908) 517-9500 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by CorMedix Inc.?
The primary purpose of this 8-K filing is to report on a Regulation FD Disclosure and Financial Statements and Exhibits, as of June 23, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on June 23, 2025.
In which state is CorMedix Inc. incorporated?
CorMedix Inc. is incorporated in Delaware.
What is the principal executive office address for CorMedix Inc.?
The principal executive office address for CorMedix Inc. is 300 Connell Drive, Suite 4200, Berkeley Heights, NJ 07922.
Does this 8-K filing disclose any new material events or financial results?
Based on the provided text, this 8-K filing is for standard reporting items (Regulation FD Disclosure, Financial Statements and Exhibits) and does not explicitly disclose any new material events or specific financial results.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding CorMedix Inc. (CRMD).